Skip to content
Confidence in biological medicines
Stay connected
Shopping Basket
Pay Now
Login / Register
Home
Products
Standardisation
Control testing
Science and research
Expert services
About us
Menu
Products
Standardisation
Control testing
Science and research
Expert services
About us
Latest news
Worldwide impact of NIBSC
Mission and values
Careers
Quality and governance
Staff profiles
Contact us
Collaborations
Suppliers
Scientific Advisory Committee
Minutes of the Animal Welfare and Ethical Review Body
Our use of animals
Privacy notice
Sub Menu
Home
/
About us
/
Latest news
/
Update on official control authority batch release (OCABR) testing following the extension to Article 50
(Withdrawn) Update on Official Control Authority Batch Release (OCABR) testing
This content was withdrawn on 31 January 2020. See
Control Testing
for current information.
During the transition period the UK will continue to hold full membership rights and the UK will continue to fulfil its obligations as a member.
NIBSC will continue to perform official control authority batch release (OCABR) testing of blood products, vaccines and other biotherapeutics for the UK and European market following guidelines of the European Directorate for the Quality of Medicines (EDQM).
This means business as usual for NIBSC whereby products tested and certified by NIBSC can continue to be marketed within Europe. NIBSC will continue to ensure batches of biological medicines are swiftly and successfully released onto the UK and European market.
If you require any further information or for any specific requirements please contact
cpb@nibsc.org
as soon as possible.